OnCore Login

HCRN Directory

Kidney

Phase II Study of High Dose Cimetidine in Renal Cell Carcinoma

Status
Cancer Types
Kidney
Locations
Read more

Phase I results of a phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC) patients previously treated with VEGFR tyrosine kinase inhibitors

Status
Cancer Types
Kidney
Locations
Read more

Phase I/II study of BNC105P in combination with everolimus or following everolimus for progressive metastatic renal cell carcinoma following prior tyrosine kinase inhibitors

Status
Cancer Types
Kidney
Locations
Read more

A Phase II Trial of Liposomal Doxil in the Treatment of Advanced Renal Cell Cancer

Status
Cancer Types
Kidney
Locations
Read more

A Phase II Hoosier Oncology Group Study of Levamisole in the Treatment of Advanced Renal Cell Cancer

Status
Cancer Types
Kidney
Locations
Read more

A Phase II Study of Altretramine for the Treatment of Metastatic Renal Cell Carcinoma

Status
Cancer Types
Kidney
Locations
Read more

A Phase II Trial of Interferon Alpha-2A Plus 5-Fluorouracil in Advanced Renal Cell Carcinoma

Status
Cancer Types
Kidney
Locations
Read more

A Phase II Trial of Vinblastine (VLB) plus Dipyridamole (DP) in Advanced Renal Cell Carcinoma (RCC)

Status
Cancer Types
Kidney
Locations
Read more

Phase I/II study of a BNC105P/everolimus regimen for progressive metastatic renal cell carcinoma (mRCC) following prior tyrosine kinase inhibitors

Status
Cancer Types
Kidney
Locations
Read more

Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced renal cell carcinoma (RCC)

Status
Cancer Types
Kidney
Locations
Read more

Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced non-clear cell renal cell carcinoma (nccRCC)

Status
Cancer Types
Kidney
Locations
Read more

1017 SLAMF7+ CD8+ exhausted T cell-specific gene signature is associated with resistance to PD1 blockade in renal cell

Status
Cancer Types
Kidney
Locations
Read more

Tumor-infiltrating CD163-positive macrophages and clinical outcomes to first-line nivolumab therapy in patients with advanced clear cell renal cell carcinoma (ccRCC)

Status
Cancer Types
Kidney
Locations
Read more

Molecular analysis of the HCRN GU16-260-Cohort A phase II study of first-line (1L) nivolumab (nivo) and salvage nivo + ipilimumab (ipi) in patients (pts) with advanced clear cell renal cell carcinoma (accRCC)

Status
Cancer Types
Kidney
Locations
Read more

Advanced renal cell cancer combination immunotherapy clinical trial (ARCITECT)

Status
Cancer Types
Kidney
Locations
Read more

A Phase II Trial of Interferon Alpha-2A Plus Fluorouracil in Advanced Renal Cell Carcinoma

Status
Cancer Types
Kidney
Locations
Read more

High Dose Cimetidine for Treatment of Metastatic Renal Cell Carcinoma

Status
Cancer Types
Kidney
Locations
Read more

A Phase II Trial of Vinblastine plus Dipyridamole in Advanced Renal Cell Carcinoma

Status
Cancer Types
Kidney
Locations
Read more

Altretamine For the Treatment of Metastatic Renal Cell Carcinoma

Status
Cancer Types
Kidney
Locations
Read more

A phase I/II trial of BNC105P with everolimus in metastatic renal cell carcinoma (mRCC)

Status
Cancer Types
Kidney
Locations
Read more

HCRN-GU22-587

Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)
Status
Cancer Types
Kidney
Locations
Beth Israel Deaconess Medical Center, California, Columbia University Irving Medical Center, Connecticut, Dana-Farber Cancer Institute, Georgetown Lombardi Comprehensive Cancer Center, Indiana, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, John Theurer Cancer Center at Hackensack Meridian Health, Massachusetts, Moores Cancer Center at UC San Diego Health, New Jersey, New York, Ohio, Penn Medicine Abramson Cancer Center, Pennsylvania, Texas, The Ohio State University, UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Washington, D.C., Weill Cornell Medicine, Winship Cancer Institute of Emory University, Yale Cancer Center
Read more

BTCRC-GU16-043

Single Arm Phase Ib/II Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer: Big Ten Cancer Research Consortium BTCRC-GU16-043
Status
Closed
Cancer Types
Kidney
Locations
Read more

HCRN-GU16-260

Phase II study of front line therapy with nivolumab and salvage nivolumab + ipilimumab in patients with advanced renal cell carcinoma
Status
Open to Accrual
Cancer Types
Kidney
Locations
Beth Israel Deaconess Medical Center, Cleveland Clinic Cancer Center, Columbia University Irving Medical Center, Connecticut, Fox Chase Cancer Center, Georgetown Lombardi Comprehensive Cancer Center, Illinois, Massachusetts, New York, Ohio, Penn Medicine Abramson Cancer Center, Pennsylvania, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Texas, University of Illinois Cancer Center, UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Washington, D.C., Winship Cancer Institute of Emory University, Yale Cancer Center
Read more

HCRN-GU17-289

A Phase II Randomized, Open label Study of High Dose Interleukin 2 vs High Dose Interleukin 2 plus Entinostat in Untreated Advanced Renal Cell Carcinoma (HCRN GU17-289)  
Status
Closed
Cancer Types
Kidney
Locations
Read more

HCRN-GU15-223

Randomized Phase II trial comparing sequential first-line sunitinib and second-line avelumab versus first-line avelumab and second-line sunitinib for metastatic renal cell carcinoma: SUAVE trial: HCRN GU15-223
Status
Closed
Cancer Types
Kidney
Locations
Read more

HCRN-GU17-326

A Phase II Study to Evaluate the Safety, Pharmacodynamics, and Efficacy of Entinostat in Combination with Nivolumab plus Ipilimumab in Patients with Renal Cell Carcinoma Previously Treated with Nivolumab plus Ipilimumab
Status
Closed
Cancer Types
Kidney
Locations
Read more

BTCRC-GU14-003

Phase Ib and Phase II Studies of Anti-PD-1 Antibody MK-3475 in Combination With Bevacizumab for the Treatment of Metastatic Renal Cell Carcinoma: Big Ten Cancer Research Consortium GU14-003
Status
Closed
Cancer Types
Kidney
Locations
Read more

GU09-145

Phase I/II Study of BNC105P in Combination With Everolimus or Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors
Status
Closed
Cancer Types
Kidney
Locations
Read more

HCRN-GU96-1

A Phase II Trial of Doxil in the Treatment of Advanced Renal Cell Cancer
Status
Closed
Cancer Types
Kidney
Locations
Read more

HCRN-GU94-1

A Phase II Trial of Levamisole in the Treatment of Advanced Renal Cell Cancer
Status
Closed
Cancer Types
Kidney
Locations
Read more

HCRN-GU91-1

A Phase II Study of Altretamine (HEX) for the Treatment of Metastatic Renal Cell Cancer
Status
Closed
Cancer Types
Kidney
Locations
Read more

HCRN-GU90-1

Phase II Study of Recombinant Interferon Alpha-2a in Metastatic Renal Cell Cancer
Status
Closed
Cancer Types
Kidney
Locations
Read more

HCRN-GU88-1

Phase II Study of Vinblastine + Dipyridamole for Metastatic Renal Cell Carcinoma
Status
Closed
Cancer Types
Kidney
Locations
Read more

HCRN-HOG-13

Phase II Study of High-Dose Cimetidine for Treatment of Metastatic Renal Cell Carcinoma
Status
Closed
Cancer Types
Kidney
Locations
Read more
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278